Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very ...
Oct 5, 2011
0
0
Researchers from the University of Michigan Comprehensive Cancer Center have identified a specific molecule that alters how breast cancer cells move. This affects the cells' ability to spread or metastasize to distant parts ...
Oct 3, 2011
0
0
Psychosocial stress could play a role in the etiology of breast cancer aggressiveness, particularly among minority populations, according to study results presented at the Fourth AACR Conference on The Science of Cancer Health ...
Sep 19, 2011
0
0
Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland ...
Sep 7, 2011
0
0
For the first time, scientists can see pathways to stop a deadly brain cancer in its tracks. Researchers at Case Western Reserve University School of Medicine have imaged individual cancer cells and the routes they travel ...
Aug 26, 2011
0
0
An international team of researchers led by Fred Hutchinson Cancer Research Center has identified five inherited genetic variants that are strongly associated with aggressive, lethal prostate cancer. The discovery ultimately ...
Aug 16, 2011
2
0
A new University of Minnesota discovery may help bone cancer patients fight their disease more effectively, according to new research published in the September issue of Bone.
Jul 28, 2011
0
0
Patients with HER2-positive breast cancer may soon have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin, according to a laboratory finding published in Clinical Cancer Research.
Jul 26, 2011
0
0
(Medical Xpress) -- A new long-term study of women with Stage IV breast cancer at the Stanford University School of Medicine is likely to revive a decade-old debate about high-dose chemotherapy as a treatment option. Specifically, ...
Jul 25, 2011
0
0
Scientists at Dana-Farber Cancer Institute have identified an overactive network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors, a typically aggressive cancer that ...
Jun 1, 2011
0
0
